Top Medical News
13 hours ago
Older men with Peyronie’s disease presenting with erectile dysfunction and extreme penile curvature are likely to report high levels of psychological distress, a study has found.
16 hours ago
Various vitamin D receptor (VDR) single nucleotide polymorphisms appear to predict nonmuscle invasive bladder cancer recurrences after bacillus Calmette-Guérin immunotherapy, suggests a recent study.
Jairia Dela Cruz, 17 hours ago
The 24-hour ambulatory or clinic blood pressure (BP) levels in hypertensive patients with reasonably well-controlled hypertension do not appear to be influenced by whether BP-lowering medications are taken in the morning or evening, according to the results of the HARMONY* trial.
Yesterday
Tacrolimus does not appear to improve erectile function recovery following nerve-sparing radical prostatectomy, a recent study has found.
Yesterday
Treatment with 5α-reductase inhibitors improves disease-specific survival following a diagnosis of bladder cancer, suggests a recent study. On the other hand, α-blockers do not appear to improve bladder cancer survival.
2 days ago
Men with cancer continue to have difficulty accessing fertility-related needs, such as accurate information about cancer heredity and sperm preservation services, a recent study has found.
2 days ago
Focal high-intensity focused ultrasound therapy appears to be effective and safe for patients with clinically significant nonmetastatic prostate cancer, a recent study has shown. 
Special Reports
Dr. Joe Lee, 12 Apr 2018

A 70-year-old male with a history of diabetes, hyperlipidaemia and hypertension managed with atenolol presented to his family physician with lower urinary tract symptoms (LUTS). He was prescribed terazosin. Over the course of a year he noticed worsening erectile dysfunction (ED) with difficulty maintaining a hard erection until orgasm.

Dr. Devdatt Palnitkar, 16 Mar 2018
Dr Devdatt Palnitkar of the Palnitkar Hospital, Aurangabad, India, shared a practical guide to treating mild to moderate Overactive bladder (OAB).
02 Nov 2017
Nocturia is the most prevalent of the lower urinary tract symptoms (LUTS) and can cause a significant negative impact on an individual’s quality of life if left untreated.1,2 In a meeting held at University Malaya Medical Centre, Associate Professor Dr Ong Teng Aik shared his insights on the management of nocturia.
Dr Jaime Songco, 31 Oct 2017

Erectile dysfunction (ED) is a common condition defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance.1 It is one of the most common complaints in men’s sexual medicine, affecting both physical and psychosocial health and having a significant impact on the patient and partner’s quality of life.1 Moreover, ED is commonly associated with other comorbid conditions, including hypertension, dyslipidaemia and diabetes mellitus.1

Evaluation of ED should include a detailed medical and sexual history of the patient. 1 A discussion of the patient and partner’s preference and treatment goals is essential to better tailor treatment and improve patient satisfaction and adherence to treatment.2 Lifestyle modification and management of risk factors should precede pharmacotherapy, while first-line treatment with oral phosphodiesterase type 5 inhibitors (PDE5i) is well established for the management of patients with ED.1

28 Sep 2017

Benign prostatic hyperplasia (BPH) is characterized by an enlargement of the prostate gland that can lead to compression of the urethra.1 Patients often experience lower urinary tract symptoms (LUTS), which are typically classified as either voiding or storage symptoms.1

Over 60% of men will experience any LUTS.2  Although Asian men typically have smaller prostates compared with Western men, Asians experience similar or higher rates of LUTS that can impact sexual function and quality of life (QoL).1,3

Conference Reports
Audrey Abella, 11 May 2018
Nanotechnology structured water was similarly effective as tadalafil in improving erectile function, suggesting that it could be a potential treatment option for erectile dysfunction (ED), according to a study presented at EAU held in Copenhagen, Denmark.
Audrey Abella, 30 Apr 2018
The selective β3-adrenoreceptor (AR) agonist vibegron showed superior efficacy over placebo for overactive bladder (OAB) treatment and was generally well-tolerated, according to a Japanese study presented at EAU 2018.

Roshini Claire Anthony, 23 Apr 2018

Targeted antibiotic prophylaxis – after a rectal swab to identify specific intestinal flora – does not appear to significantly impact the risk of urinary sepsis following a transrectal ultrasound (TRUS)-guided prostate biopsy, according to a recent study.

Roshini Claire Anthony, 20 Apr 2018

Conservative management appears to be the favoured option in managing non-penetrating renal trauma with urinary extravasation, according to a study presented at EAU 2018.

Christina Lau, 16 Apr 2018

MRI, with or without targeted biopsy, detects more clinically significant prostate cancer and less clinically insignificant prostate cancer than the standard transrectal ultrasonography (TRUS)-guided approach, enabling more than one-quarter of patients to safely avoid a biopsy altogether.

Christina Lau, 12 Apr 2018

Men with nonmetastatic castration-resistant prostate cancer (CRPC) have similar health-related quality of life (HRQoL) with apalutamide given on top of androgen deprivation therapy (ADT) vs ADT alone, according to new data from the SPARTAN (Prostate Androgen Receptor Targeting with ARN-509) trial presented at the European Association of Urology (EAU) 2018 Congress.

Christina Lau, 02 Apr 2018

Patients with urologic cancers are more likely to attempt suicide, highlighting the need for increased psychiatric intervention for these patients at an earlier stage, according to findings presented at the European Association of Urology (EAU) 2018 Congress.